12
total announcements
540737.BO · 15 min delayed
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd has announced the closure of its trading window from October 1, 2026, until 48 hours after the declaration of its unaudited financial results for the quarter and half year ended September 30, 2026.
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd has announced the voting results of its 31st Annual General Meeting, which was held through video conferencing on September 12, 2026. The meeting approved the audited standalone and consolidated financial statements for the financial year ended March 31, 2026, and also appointed a director in place of Mr. Chandulal Manubhai Kothia.
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd has announced the outcome of its Annual General Meeting (AGM), where shareholders approved various resolutions.
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd has published a notice of its 31st Annual General Meeting and e-voting information in newspapers as required by law.
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd has announced its Annual Report FY 2025-26 and Notice of 31st Annual General Meeting. The AGM will be held on September 12, 2026, through Video Conferencing. The company has also uploaded the reports on its website and sent them to shareholders through email.
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd has published a newspaper advertisement for their unaudited standalone and consolidated financial results for the quarter ended June 30, 2026, as per Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd has announced its unaudited financial results for Q1FY27, showing a challenging quarter due to subdued demand, geopolitical uncertainty, and raw material market volatility. The company's revenue, EBITDA, and PAT have declined YoY by 42%, 54%, and 68%, respectively. The CRAMS pipeline remains on track, and the company expects a meaningful improvement in performance in the second half of FY27.
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd reported Q1FY27 results with revenue down 42% YoY and PAT down 68% YoY due to subdued European demand and raw material volatility. The company expects a timing issue in the second half of FY27 but remains confident in its long-term growth prospects.
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd has announced the appointment of Cost Auditors for the year 2026-2027 and the unaudited financial results for the quarter ended June 30, 2026.
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, along with the appointment of a new cost auditor and other board decisions.
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, and has also appointed M/s. M. I. Prajapati & Associates LLP as Cost Auditors for the year 2026-2027.
Shree Ganesh Remedies Ltd
Shree Ganesh Remedies Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 12/08/2026 to consider and approve the Unaudited (Standalone and Consolidated) Financial Results of the Company for the quarter ended on June 30, 2026.